Finland Sees Progress On Biosimilar Substitution Plans
Updated Proposals Reflect Industry Criticism; Parliamentary Approval Expected In Weeks
Executive Summary
Updated plans to implement pharmacy-level biosimilar substitution in Finland have just been published by a parliamentary health committee ahead of expected formal approval within weeks, reflecting certain industry criticisms that have now been taken on board.